| ²é¿´: 2886 | »Ø¸´: 2 | ||
shumch½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖúĪɳ±ØÀûÔÑÐÇé¿ö
|
| ÇóÖúèÛéÚËáĪɳ±ØÀû¹ú¼ÊÉÏÊ״λñÅúÉÏÊеÄʱ¼äºÍÔÑй«Ë¾¡¢Åú×¼µ¥Î»Çé¿ö |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
ÇóÖú¡¶ÉúÎïÀûÓöȺÍÉúÎïµÈЧÐÔÑо¿Ö¸µ¼ÔÔò¡·£¨ÊÔ ÐУ©£¬2002
ÒѾÓÐ0È˻ظ´
ÎÄÏ×ÇóÖú
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ293È˻ظ´
[ÇóÖú] Á÷ʽËÀ»îȾ & µ¥Ï¸°ûÃÅ¿ØÉèÖñ»ÖÊÒÉ£¬ÈçºÎÓÅ»¯²¢½âÊÍ£¿
ÒѾÓÐ1È˻ظ´
µ°°×Îȶ¨ÐÔʵÑéÓ빦ÄÜʵÑé²»Ò»ÖÂ
ÒѾÓÐ11È˻ظ´
µÚ4ÄêÁË£¬ÂíÉÏ40ÁË£¬¿ÉÄÜÎÒÓë¹ú»ùȷʵÎÞÔµ°É¡£¡£¡£
ÒѾÓÐ12È˻ظ´
2026ÄêÉ격ҩѧרҵ
ÒѾÓÐ1È˻ظ´
ҩѧר˶É격
ÒѾÓÐ5È˻ظ´
¿ÉÄÜÉϲ»Á˰¶£¿ÓÐÌõ¼þµÄ¿ÉÒÔ¿¼ÂÇÆäËû³ö·
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
[ÇóÖú] ¹ØÓÚÏõ»ù»¹Ô³É°±»ùµÄ·½·¨£¬´óÉñ°ïæ°¡£¡£¡£¡
ÒѾÓÐ66È˻ظ´
¡¾ÇóÖú¡¿Ç볤´ºÓ¦Óû¯Ñ§Ñо¿ËùµÄ³æÓѰïϲ©Ê¿ÂÛÎÄ¡¾ÓÐЧÆÚÖÁ2011Äê5ÔÂ21ºÅ¡¿
ÒѾÓÐ11È˻ظ´
¡¾ÇóÖú¡¿µÚÒ»ÐÔÔÀíÑо¿ï®Àë×Óµç³ØÕý¼«²ÄÁϵÄÎÄÕ¶¼¼¯ÖÐÔÚÄÄЩ¿¯ÎïÉÏ£¿
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿¸ÖÔ°ÂÊÏÌå¾§½çÇÖÊ´ÇóÖú
ÒѾÓÐ24È˻ظ´
¡¾ÇóÖú¡¿¹úÍâ·ÃѧµÄÑо¿¼Æ»®
ÒѾÓÐ10È˻ظ´
¡¾ÇóÖú¡¿½µÎÂÎö³ö¶¯Á¦Ñ§Ñо¿
ÒѾÓÐ11È˻ظ´
¡¾ÇóÖú¡¿ÈçºÎ²éѯһ¸öÒ©Æ·µÄÔÑг§¼Ò£¿
ÒѾÓÐ10È˻ظ´
ÇóÖúÕý½»·ÖÎö
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿µ¼Ê¦¸øÁ˸öÑо¿·½Ïò¡°»ùÓÚ²©ÞÄÀíÂÛµÄÍøÂ簲ȫÖ÷¶¯·ÀÓù¡±£¬´ó¼Ò¸øµãÒâ¼û
ÒѾÓÐ36È˻ظ´
shumch
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1148.6
- ºì»¨: 2
- Ìû×Ó: 258
- ÔÚÏß: 51.4Сʱ
- ³æºÅ: 1195320
- ×¢²á: 2011-01-24
- רҵ: ºÏ³ÉÒ©Îﻯѧ
2Â¥2012-07-17 10:36:48
beautydrug
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 14 (СѧÉú)
- ½ð±Ò: 1848.8
- ºì»¨: 2
- Ìû×Ó: 314
- ÔÚÏß: 190.5Сʱ
- ³æºÅ: 1582078
- ×¢²á: 2012-01-18
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+5, ллӦÖú£¬ÐÁ¿àÁË£¬»¶Ó³£À´Å¶¡£ 2012-07-17 14:06:40
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
³ÕÒÄ×ÓÆ¤: ½ð±Ò+5, ллӦÖú£¬ÐÁ¿àÁË£¬»¶Ó³£À´Å¶¡£ 2012-07-17 14:06:40
|
¸÷¹úÉÏÊÐÈÕÆÚ£º Country Name Status Year Launched Licensing Op. Argentina - No Australia - No Austria - No Belgium - No Brazil - No Canada Phase II Clinical Trial No Chile - No China Launched 2001 No Colombia - No Denmark - No Finland - No France - No Germany - No Greece - No Hong Kong - No India - No Ireland - No Israel - No Italy - No Japan Launched 1998 No Luxembourg - No Malaysia Registered No Mexico - No Netherlands - No New Zealand - No Norway - No Peru - No Philippines Launched No Portugal - No Russian Federation - No South Africa - No South Korea Launched 2002 No Spain Phase II Clinical Trial No Sweden Phase II Clinical Trial No Switzerland - No Thailand Launched No Turkey - No UK - No USA Phase III Clinical Trial No Venezuela - No Indication Status Motility dysfunction, GI, unspecified Discontinued Gastritis Launched Dyspepsia, non-ulcer Launched Gastro-oesophageal reflux Discontinued Post-gastrectomy syndrome Discontinued ÔÑУº Dainippon Sumitomo Pharma Japan Launched ÊÚȨ³§ÉÌ£º Takeda Japan Launched Daewoong South Korea Launched Eisai Japan Launched |

3Â¥2012-07-17 13:59:36














»Ø¸´´ËÂ¥
shumch
10